Why Gaps Happen (and Why They're More Common Than You Think)
Treatment gaps on GLP-1 medications are extremely common. Financial constraints cause some patients to skip months. Insurance plan changes disrupt coverage. Pregnancy planning requires a pause. Surgery mandates a pre-operative hold. Travel makes cold-chain storage impractical. Life happens, and the medication gets interrupted.
What matters isn't that you had a gap — it's how you restart. The single most important thing to know: your gastrointestinal tolerance resets during a break. Even if you were comfortably taking 2.4 mg of semaglutide before your gap, restarting at that dose after several weeks off will likely produce the same nausea, vomiting, and GI distress you experienced during initial titration — or worse.
The restart protocol your prescriber uses depends on how long you were off the medication and what dose you were on when you stopped.
Restart Protocols by Gap Length
| Gap Length | Typical Restart Protocol | Time Back to Previous Dose |
|---|---|---|
| 1-2 weeks | Resume at your current dose | Immediate |
| 2-4 weeks | Drop one titration step; resume escalation | 4-8 weeks |
| 4-8 weeks | Restart at 50% of previous dose | 8-12 weeks |
| 8+ weeks | Restart from the beginning (0.25 mg sema or equivalent) | Full retitration (16-20 weeks) |
These are general guidelines — your prescriber may adjust based on your individual tolerance history, the reason for the gap, and any changes in your health status since stopping.
Embody
Top Pick — $400 CPA
From $249/mo
Injectable semaglutide only. Compounded — not FDA-approved.
Paid link Check Eligibility →What Your Prescriber Needs to Know Before Restarting
When you contact your prescriber about restarting, come prepared with this information:
Exactly how long you've been off the medication. The restart protocol depends on this number. Be precise — "a few months" doesn't give your prescriber enough information to dose safely.
What dose you were on when you stopped. This determines the starting point for your restart titration.
Why you stopped. If you stopped due to side effects, your prescriber may adjust the restart approach — perhaps titrating more slowly, adding supportive medications for nausea, or considering a switch to a different GLP-1.
Any health changes during the gap. New medications, new diagnoses, pregnancy, surgery, significant weight changes — all of these affect the restart plan.
Whether you have existing medication supply. If you have unused vials or pens from before the gap, check expiration dates and confirm proper storage. Semaglutide that's been at room temperature for more than 56 days (for pens) or that's past its beyond-use date (for compounded vials) should not be used.
Managing the Emotional Side of Restarting
Restarting can feel discouraging. You may have regained some or all of the weight you lost during your initial treatment. You're facing another round of titration side effects. The timeline to get back to your effective dose feels long.
Three things that help:
Reframe the gap as data. If you regained weight during the gap, that's actually useful clinical information — it confirms that your body responds to GLP-1 therapy and that ongoing treatment is medically appropriate. This data strengthens any future insurance coverage requests.
Side effects are usually milder on restart. Many patients report that retitration is easier than the initial titration. Your body has some metabolic memory of the medication, and you already know what foods, timing, and hydration strategies work for you.
The retitration period is faster than starting from scratch. Even if you restart at the lowest dose, many prescribers will accelerate the titration schedule for patients who previously tolerated higher doses — stepping up every 2-3 weeks instead of every 4 weeks, as long as tolerance permits.
Care Bare Rx
Quick Start
From $199/mo
Compounded — not FDA-approved.
Paid link Check Eligibility →Telos Rx
Tirzepatide Specialist
From $199/mo
Compounded tirzepatide — not FDA-approved.
Paid link Check Eligibility →